{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:24:51Z","timestamp":1774380291955,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This research investigated the risk factors and multimodal imaging characteristics associated with the onset of central serous chorioretinopathy (CSCR) in the contralateral eye during follow-up of patients initially presenting with unilateral complex CSCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this retrospective cohort, patients observed between 2015 and 2023 were classified into two groups: those progressing from unilateral to bilateral CSCR formed the study group, whereas patients who did not develop contralateral disease during follow-up comprised the control group. Demographic characteristics and smoking status were recorded. Multimodal imaging was documented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 126 eyes from 63 patients were evaluated, including 31 with bilateral disease (Group 1) and 32 with unilateral CSCR (Group 2). In Group 1, the mean interval between involvement of the first and second eye was 21.29 \u00b1 18.46 months. At baseline, the mean subfoveal choroidal thickness in affected eyes was 293 \u00b1 67\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      m in the study group, significantly lower than the 356 \u00b1 64\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                      m observed in controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Multivariate regression analysis demonstrated that smoking, the presence of CSCR-related changes in the fellow eye on initial fundus fluorescein angiography (FFA), and reduced choroidal thickness in the first affected eye were independent predictors of bilateral disease progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings indicate that smoking, early CSCR-related changes in the contralateral eye on baseline FFA, and reduced choroidal thickness in the initially affected eye represent significant risk factors for bilateral CSCR development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004744","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:06:57Z","timestamp":1774368417000},"page":"690-697","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CLINICAL AND IMAGING PREDICTORS OF BILATERAL INVOLVEMENT IN CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2096-9263","authenticated-orcid":false,"given":"Oyku","family":"Okur","sequence":"first","affiliation":[{"name":"University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-9829","authenticated-orcid":false,"given":"Metehan","family":"Simsek","sequence":"additional","affiliation":[{"name":"Dogubayazit Dr. Yasar Eryilmaz State Hospital, Agri, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-5718","authenticated-orcid":false,"given":"Merve","family":"Ozbek","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5653-5800","authenticated-orcid":false,"given":"Sad\u0131k G\u00f6rkem","family":"\u00c7evik","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-7393","authenticated-orcid":false,"given":"Ozgur","family":"Artunay","sequence":"additional","affiliation":[{"name":"University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20260324","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10384-024-01101-2","article-title":"Central serous chorioretinopathy and the sclera: what we have learned so far","volume":"68","author":"Koizumi","year":"2024","journal-title":"Jpn J Ophthalmol"},{"key":"R3-20260324","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R4-20260324","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/ojo.OJO_75_2017","article-title":"Central serous chorioretinopathy: current update on pathophysiology and multimodal imaging","volume":"11","author":"Manayath","year":"2018","journal-title":"Oman J Ophthalmol"},{"key":"R5-20260324","first-page":"e23446","article-title":"Bilateral central serous chorioretinopathy after treatment of COVID-19 infection","volume":"14","author":"Sharifi","year":"2022","journal-title":"Cureus"},{"key":"R6-20260324","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4274\/tjo.galenos.2023.75233","article-title":"Surgical treatment of bullous exudative retinal detachment secondary to atypical bilateral central serous chorioretinopathy","volume":"53","author":"\u00d6zdemir","year":"2023","journal-title":"Turk J Ophthalmol"},{"key":"R7-20260324","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.oftal.2017.01.002","article-title":"Bilateral exudative retinal detachment associated with central serous chorioretinopathy in a patient treated with corticosteroids","volume":"92","author":"Rueda-Rueda","year":"2017","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R8-20260324","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients","volume":"103","author":"Ersoz","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"R9-20260324","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","article-title":"Multimodal imaging-based central serous chorioretinopathy classification","volume":"4","author":"Chhablani","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R10-20260324","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41433-021-01885-4","article-title":"Imaging characteristics of bilateral CSCR cases: 12 months follow up","volume":"37","author":"Singh","year":"2023","journal-title":"Eye (Lond)"},{"key":"R11-20260324","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.1038\/s41598-021-96715-8","article-title":"Optical coherence tomography angiography (OCTA) of retinal vasculature in patients with post fever retinitis: a qualitative and quantitative analysis","volume":"11","author":"Sanjay","year":"2021","journal-title":"Sci Rep"},{"key":"R12-20260324","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000360014","article-title":"Central serous chorioretinopathy","volume":"232","author":"Liegl","year":"2014","journal-title":"Ophthalmologica"},{"key":"R13-20260324","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R14-20260324","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/IAE.0000000000003692","article-title":"Distinct characteristics of simple versus complex central serous chorioretinopathy","volume":"43","author":"Yoneyama","year":"2023","journal-title":"Retina"},{"key":"R15-20260324","doi-asserted-by":"crossref","first-page":"100865","DOI":"10.1016\/j.preteyeres.2020.100865","article-title":"Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities","volume":"79","author":"Kaye","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"R16-20260324","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1177\/11206721241287253","article-title":"Longitudinal structural changes in central serous chorioretinopathy: a multimodal imaging-based study","volume":"35","author":"Sahoo","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"R17-20260324","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bjophthalmol-2020-317422","article-title":"Central serous chorioretinopathy imaging biomarkers","volume":"106","author":"Singh","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R18-20260324","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.4103\/ijo.IJO_2030_18","article-title":"Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy","volume":"67","author":"Hanumunthadu","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R19-20260324","first-page":"1561","article-title":"Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy","volume":"104","author":"Chen","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R20-20260324","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/jcm14051458","article-title":"Treatment outcomes of simple and complex central serous chorioretinopathy","volume":"14","author":"Kamao","year":"2025","journal-title":"J Clin Med"},{"key":"R21-20260324","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00417-020-04623-w","article-title":"Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents","volume":"258","author":"Schworm","year":"2020","journal-title":"Graefe's Archive Clin Exp Ophthalmol"},{"key":"R22-20260324","doi-asserted-by":"crossref","first-page":"1272524","DOI":"10.1155\/2022\/1272524","article-title":"The efficacy of anti-VEGF therapy for putative or visible CNV in central serous chorioretinopathy by optical coherence tomography angiography","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Ophthalmol"},{"key":"R23-20260324","doi-asserted-by":"crossref","first-page":"5970659","DOI":"10.1155\/2019\/5970659","article-title":"Risk factors for persistent or recurrent central serous chorioretinopathy","volume":"2019","author":"Yu","year":"2019","journal-title":"J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:07:01Z","timestamp":1774368421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004744","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}